Overview

Why Invest

Profitable specialty pharmaceutical company with a diversified portfolio 

Cipher’s lean operating structure and collaborative approach to commercialization and development enable rapid and efficient scaling while maximizing our profitability.

  •  
  • Solid dermatology platform
  •  
  • Established presence across the Americas
  •  
  • Strong balance sheet
  •  
  • History of positive operating cash flow
  •  
  • Robust pipeline
  •  
  • Proven leadership team

Download Investor Presentation

Latest News
Mar 14, 2024

(All figures are presented in U.S. Dollars) Cash at December 31, 2023 was $39.8 million (CDN$52.7 million) or $1.66 per outstanding common share (CDN$2.20) Full year adjusted EBITDA of $12.7...

Mar 8, 2024

Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the fourth quarter and full year of 2023 after the...

Jan 29, 2024

Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or "the Company") is proud to announce that its common shares are now trading on the OTCQX® Best Market ("OTCQX") under the symbol...

More News >

Ticker
TSXCPH
Latest Event

Annual Reports

Quarterly Reports